Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2025-12-24 @ 2:51 PM
NCT ID:
NCT03929159
Eligibility Criteria:
Inclusion Criteria:
* Electively scheduled for surgical operation that require general anesthesia and expected duration of hospitalization of longer than one day (for patients in Perioperative Evaluation \& Management \[POEM\]) or high clinical suspicion of sepsis by the emergency physician (for patients in emergency center)
* Ability to give informed consent. If the patient is incapacitated and unable to give informed consent, the next-of-kin or a person who has the power of attorney must be present for informed consent.
* For patients in the emergency center only, two or more of the following SIRS criteria:
* Leukocytes \> 12,000/mm\^3 or \< 4,000/mm\^3 or \> 10% immature (band) forms, provided that no filgrastim or pegfilgrastim was administered within 30 days and no leukemia
* Heart rate \> 90 beats/minute (min)
* Respiratory rate \> 20 breaths/min or partial pressure of carbon dioxide (CO2) \< 32 mmHg
* Oral temperature \> 38 degrees Celsius (C) or \< 36 degrees C or axillary temperature \> 37 degrees C or \< 35 degrees C
Exclusion Criteria:
* Inability to give informed consent or a person who has power of attorney for medical decision is not available
* Being moribund (for patients in emergency center) or cancellation of surgery (for patients in POEM)
* Active "Do Not Resuscitate" or "Do Not Intubate" order
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03929159
Study Brief:
Protocol Section:
NCT03929159